EU | pharmaphorum

EU

News

Radiology technician examens mammography test on location

AZ, Merck get EU nod for Lynparza as adjuvant breast cancer ...

The European Commission has cleared AstraZeneca and Merck & Co's Lynparza as an adjuvant treatment for breast cancer, extending its lead over would-be rivals in the PARP inhibitor class

News

AZ, Daiichi challenge Roche with EU okay for earlier use of ...

AstraZeneca and Daiichi Sankyo have claimed approval in the EU for Enhertu as a second-line therapy for HER2-positive metastatic breast cancer, moving the drug up the treatment pathway.

News

Chasing rivals, AbbVie files migraine prevention drug atogep...

AbbVie has submitted its oral CGRP inhibitor atogepant for prevention of both episodic and chronic migraine in the EU as it tries to catch up with main rivals Pfizer/BioHaven and their rece

News

Celebrations for ASMD community as EU clears Sanofi's Xenpoz...

Sanofi has claimed approval in the EU for Xenpozyme as a treatment for acid sphingomyelinase deficiency (ASMD) – which becomes the first and only treatment option for patients with the rare

News

BioMarin gene therapy for haemophilia on course for EU appro...

The EMA's human medicines advisory committee has recommended that BioMarin Pharmaceutical's haemophilia A gene therapy Roctavian be approved in the EU, removing one of the last barriers to

News